The p53 orchestra: Mdm2 and Mdmx set the tone

被引:354
作者
Wade, Mark [1 ]
Wang, Yunyuan V. [1 ]
Wahl, Geoffrey M. [1 ]
机构
[1] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA
关键词
ACCELERATES TUMOR-FORMATION; UBIQUITIN LIGASE ACTIVITY; B-CELL LYMPHOMAS; RING DOMAIN; POSTTRANSLATIONAL MODIFICATIONS; FUNCTIONAL-ANALYSIS; SUPPRESSOR PATHWAY; PROTEIN STABILITY; NUCLEAR EXPORT; ACTIVATES P53;
D O I
10.1016/j.tcb.2010.01.009
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The activities of p53 cover diverse aspects of cell biology, including cell cycle control, apoptosis, metabolism, fertility, differentiation and cellular reprogramming. Although loss of p53 function engenders tumor susceptibility, hyperactivation of p53 is lethal. Therefore, p53 activity must be strictly regulated to maintain normal tissue homeostasis. Critical for the control of p53 function are its two main negative regulators: Mdm2 and Mdmx. Recent reports have provided insight into the complex mechanisms that regulate these two proteins and have revealed novel functions for each. Here, we review and evaluate models of Mdm2- and Mdmx-dependent regulation of p53 activity. Both Mdm2 and Mdmx receive input from numerous signaling pathways and interact with many proteins in addition to p53. Therefore, we also consider roles for Mdm2 and Mdmx in additional cancer-related networks, including Notch signaling and the epithelial-to-mesenchymal transition.
引用
收藏
页码:299 / 309
页数:11
相关论文
共 129 条
[1]   MdmX is a substrate for the deubiquitinating enzyme USP2a [J].
Allende-Vega, N. ;
Sparks, A. ;
Lane, D. P. ;
Saville, M. K. .
ONCOGENE, 2010, 29 (03) :432-441
[2]   Reassessing the role of p53 in cancer and ageing from an evolutionary perspective [J].
Aranda-Anzaldo, Armando ;
Dent, Myrna A. R. .
MECHANISMS OF AGEING AND DEVELOPMENT, 2007, 128 (04) :293-302
[3]   Suppression of p53 by Notch in lymphomagenesis: Implications for initiation and regression [J].
Beverly, LJ ;
Felsher, DW ;
Capobianco, AJ .
CANCER RESEARCH, 2005, 65 (16) :7159-7168
[4]   Mdm2, but not Mdm4, protects terminally differentiated smooth muscle cells from p53-mediated caspase-3-independent cell death [J].
Boesten, L. S. M. ;
Zadelaar, S. M. ;
De Clercq, S. ;
Francoz, S. ;
van Nieuwkoop, A. ;
Biessen, E. A. L. ;
Hofmann, F. ;
Feil, S. ;
Feil, R. ;
Jochemsen, A. G. ;
Zurcher, C. ;
Havekes, L. M. ;
van Vlijmen, B. J. M. ;
Marine, J. -C .
CELL DEATH AND DIFFERENTIATION, 2006, 13 (12) :2089-2098
[5]   MDM2 SNP309 accelerates tumor formation in a gender-specific and hormone-dependent manner [J].
Bond, Gareth L. ;
Hirshfield, Kim M. ;
Kirchhoff, Tomas ;
Alexe, Gabriella ;
Bond, Elisabeth E. ;
Robins, Harlan ;
Bartel, Frank ;
Taubert, Helge ;
Wuerl, Peter ;
Hait, William ;
Toppmeyer, Deborah ;
Offit, Kenneth ;
Levine, Arnold J. .
CANCER RESEARCH, 2006, 66 (10) :5104-5110
[6]   A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans [J].
Bond, GL ;
Hu, WW ;
Bond, EE ;
Robins, H ;
Lutzker, SG ;
Arva, NC ;
Bargonetti, J ;
Bartel, F ;
Taubert, H ;
Wuerl, P ;
Onel, K ;
Yip, L ;
Hwang, SJ ;
Strong, LC ;
Lozano, G ;
Levine, AJ .
CELL, 2004, 119 (05) :591-602
[7]   p53 ubiquitination: Mdm2 and beyond [J].
Brooks, CL ;
Gu, W .
MOLECULAR CELL, 2006, 21 (03) :307-315
[8]   Binding and recognition in the assembly of an active BRCA1 /BARD1 ubiquitin-ligase complex [J].
Brzovic, PS ;
Keeffe, JR ;
Nishikawa, H ;
Miyamoto, K ;
Fox, D ;
Fukuda, M ;
Ohta, T ;
Klevit, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (10) :5646-5651
[9]   C-terminal modifications regulate MDM2 dissociation and nuclear export of p53 [J].
Carter, Stephanie ;
Bischof, Oliver ;
Dejean, Anne ;
Vousden, Karen H. .
NATURE CELL BIOLOGY, 2007, 9 (04) :428-U111
[10]   Ser18 and 23 phosphorylation is required for p53-dependent apoptosis and tumor suppression [J].
Chao, Connie ;
Herr, Deron ;
Chun, Jerold ;
Xu, Yang .
EMBO JOURNAL, 2006, 25 (11) :2615-2622